Back to LCTX
KBC Group NV LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
5
Latest value
$90K
Q3 2026
Peak value
$114K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $102K |
| Q4 2025 | $92K |
| Q1 2026 | $86K |
| Q2 2026 | $114K |
| Q3 2026 | $90K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $90K | 2.6K | — | — |
| Q2 2026 | $114K | 2.6K | — | — |
| Q1 2026 | $86K | 2.6K | — | — |
| Q4 2025 | $92K | 2.6K | — | — |
| Q3 2025 | $102K | 2.6K | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M